Diabetes Complications and Hearing Loss

Diabetes Mellitus Clinical Trial

Official title:

The Relationship Between Diabetes, Its Neurological and Optical Complications, and Hearing Loss.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06190938
• Other study ID #: Observation
• Status: Completed
• Start date: June 23, 2022
• Est. completion date: December 22, 2022

Study information

• Verified date: December 2023
• Source: Syrian Private University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Observation study, shows the relation between diabetes, its neurological and optical complication and hearing loss, by asking participants questions about there age,BMI,job,the history of any cataract,diabetes retinopathy or heart attack,hypertension,swollen or tingling legs and take there consent to measure the hearing impairment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 87
• Est. completion date: December 22, 2022
• Est. primary completion date: November 12, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Diabetics who signed consent for the study.

• Diabetics who have filled out the form completely.

• Diabetics who have undergone a pure tone hearing screening test .

Exclusion Criteria:

• Patients with glandular disease causing hearing loss.

• Patients with traumatic ear injury.

• Patients who have recently had a middle or inner ear infection.

• History of acoustic neuroma.

• Patients are under active treatment with medications that have a toxic effect on the auditory cells.

• Patients with diabetic foot.

• The patient's occupation or residence is within a noisy environment.

Related Conditions & MeSH terms

• Deafness
• Diabetes Complications
• Diabetes Mellitus
• Hearing Loss

Locations

Country	Name	City	State
Syrian Arab Republic	Mohamad Zaid Ahmad Abdalla	Damascus

Sponsors (1)

Lead Sponsor	Collaborator
Syrian Private University

Country where clinical trial is conducted

Syrian Arab Republic, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The Demographic characteristics were classified into four groups: Gender, Financial status, Educational level, and Profession.	Gender was either male or female. Income was divided into three categories: Low Income (those who were unable to provide even the basics for themselves), Fair Income (basics and some additional expenses), and High Income. Professions were divided into four types: Retired, Housewife, Worker and Student. Educational degree was categorized as Lower than High School, High School, or Higher than High School. Hypertension was measured and considered higher than normal when exceeded 140/90 mmHg. Both height and weight were measured to calculate the BMI of each subject.; Weight was measured in kilograms. Height was measured in meters. BMI that scored less than 25, between 25-30, 30 or more was considered, underweight normal, and obese respectively.; "The number of patients diagnosed with diabetes who showed signs of hearing impairment at certain stages of their lives, and how this related to other neurological signs, is being investigated.	The study took 6 months to finish it with hard work, it was hard to reach our participants so it tooks 2 weeks from us for each participant to finish our survey